Cargando…
Building clinical trial priorities at the University of Rwanda
After the genocide in Rwanda, the country’s healthcare system collapsed. Remarkable gains have since been made by the state to provide greater clinical service capacity and expand health policies that are grounded on locally relevant evidence. This commentary explores the challenges faced by Rwanda...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289206/ https://www.ncbi.nlm.nih.gov/pubmed/25429819 http://dx.doi.org/10.1186/1745-6215-15-467 |
_version_ | 1782352065770553344 |
---|---|
author | Condo, Jeanine Kateera, Brenda Mutimura, Eugene Birungi, Francine Ndagijimana, Albert Jansen, Stefan Kamwesiga, Julius Forrest, Jamie I Mills, Edward J Binagwaho, Agnes |
author_facet | Condo, Jeanine Kateera, Brenda Mutimura, Eugene Birungi, Francine Ndagijimana, Albert Jansen, Stefan Kamwesiga, Julius Forrest, Jamie I Mills, Edward J Binagwaho, Agnes |
author_sort | Condo, Jeanine |
collection | PubMed |
description | After the genocide in Rwanda, the country’s healthcare system collapsed. Remarkable gains have since been made by the state to provide greater clinical service capacity and expand health policies that are grounded on locally relevant evidence. This commentary explores the challenges faced by Rwanda in building an infrastructure for clinical trials. Through local examples, we discuss how a clinical trial infrastructure can be constructed by (1) building educational capacity; (2) encouraging the testing of relevant interventions using appropriate and cost-effective designs; and, (3) promoting ethical and regulatory standards. The future is bright for clinical research in Rwanda and with a renewed appetite for locally generated evidence it is necessary that we discuss the challenges and opportunities in drawing up a clinical trials agenda. |
format | Online Article Text |
id | pubmed-4289206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42892062015-01-11 Building clinical trial priorities at the University of Rwanda Condo, Jeanine Kateera, Brenda Mutimura, Eugene Birungi, Francine Ndagijimana, Albert Jansen, Stefan Kamwesiga, Julius Forrest, Jamie I Mills, Edward J Binagwaho, Agnes Trials Commentary After the genocide in Rwanda, the country’s healthcare system collapsed. Remarkable gains have since been made by the state to provide greater clinical service capacity and expand health policies that are grounded on locally relevant evidence. This commentary explores the challenges faced by Rwanda in building an infrastructure for clinical trials. Through local examples, we discuss how a clinical trial infrastructure can be constructed by (1) building educational capacity; (2) encouraging the testing of relevant interventions using appropriate and cost-effective designs; and, (3) promoting ethical and regulatory standards. The future is bright for clinical research in Rwanda and with a renewed appetite for locally generated evidence it is necessary that we discuss the challenges and opportunities in drawing up a clinical trials agenda. BioMed Central 2014-11-27 /pmc/articles/PMC4289206/ /pubmed/25429819 http://dx.doi.org/10.1186/1745-6215-15-467 Text en © Condo et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Condo, Jeanine Kateera, Brenda Mutimura, Eugene Birungi, Francine Ndagijimana, Albert Jansen, Stefan Kamwesiga, Julius Forrest, Jamie I Mills, Edward J Binagwaho, Agnes Building clinical trial priorities at the University of Rwanda |
title | Building clinical trial priorities at the University of Rwanda |
title_full | Building clinical trial priorities at the University of Rwanda |
title_fullStr | Building clinical trial priorities at the University of Rwanda |
title_full_unstemmed | Building clinical trial priorities at the University of Rwanda |
title_short | Building clinical trial priorities at the University of Rwanda |
title_sort | building clinical trial priorities at the university of rwanda |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289206/ https://www.ncbi.nlm.nih.gov/pubmed/25429819 http://dx.doi.org/10.1186/1745-6215-15-467 |
work_keys_str_mv | AT condojeanine buildingclinicaltrialprioritiesattheuniversityofrwanda AT kateerabrenda buildingclinicaltrialprioritiesattheuniversityofrwanda AT mutimuraeugene buildingclinicaltrialprioritiesattheuniversityofrwanda AT birungifrancine buildingclinicaltrialprioritiesattheuniversityofrwanda AT ndagijimanaalbert buildingclinicaltrialprioritiesattheuniversityofrwanda AT jansenstefan buildingclinicaltrialprioritiesattheuniversityofrwanda AT kamwesigajulius buildingclinicaltrialprioritiesattheuniversityofrwanda AT forrestjamiei buildingclinicaltrialprioritiesattheuniversityofrwanda AT millsedwardj buildingclinicaltrialprioritiesattheuniversityofrwanda AT binagwahoagnes buildingclinicaltrialprioritiesattheuniversityofrwanda |